SCHEMBL7884372

SCHEMBL7884372

CN(C(=N)N)C(=O)c1cc2c(Cl)cc(Oc3ccc(N)cc3)cc2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 4/20 0.39
EIF4A3 P38919 1/20 0.36
CHEK2 O96017 5/20 0.35
FLT3 P36888 1/20 0.35
PARP10 Q53GL7 1/20 0.35
GRIN1 Q05586 1/20 0.34
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ST14 Q9Y5Y6 3/20 0.33
F2 P00734 2/20 0.33
PRSS1 P07477 2/20 0.33
PRSS2 P07478 2/20 0.33
PRSS3 P35030 2/20 0.33
THRA P10827 1/20 0.32
THRB P10828 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7884300 0.99 RHEB (0.38) RHEBEIF4A3CHEK2FLT3PARP10
SCHEMBL7879889 0.90 RHEB (0.50) RHEBEIF4A3FLT3GRIN1MEN1
SCHEMBL7882347 0.89 RHEB (0.39) RHEBEIF4A3CHEK2FLT3GRIN1
SCHEMBL7879405 0.89 ST14 (0.41) RHEBEIF4A3CHEK2FLT3GRIN1
SCHEMBL7873184 0.88 RHEB (0.38) RHEBEIF4A3CHEK2FLT3GRIN1
Hydrochloric Acid SCHEMBL7873497 0.88 RHEB (0.39) RHEBEIF4A3CHEK2FLT3GRIN1
Hydrochloric Acid SCHEMBL7881143 0.88 ST14 (0.40) RHEBEIF4A3CHEK2FLT3GRIN1
SCHEMBL7877541 0.88 HTR2A (0.39) RHEBCHEK2FLT3GRIN1THRA
SCHEMBL7879699 0.87 MEN1 (0.41) RHEBCHEK2ALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL7881325 0.87 HTR2A (0.38) RHEBCHEK2FLT3GRIN1THRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed